Intragenic ATM methylation in peripheral blood DNA as a biomarker of breast cancer risk.

Few studies have evaluated the association between DNA methylation in white blood cells (WBC) and the risk of breast cancer. The evaluation of WBC DNA methylation as a biomarker of cancer risk is of particular importance as peripheral blood is often available in prospective cohorts and easier to obtain than tumor or normal tissues. Here, we used prediagnostic blood samples from three studies to analyze WBC DNA methylation of two ATM intragenic loci (ATMmvp2a and ATMmvp2b) and genome-wide DNA methylation in long interspersed nuclear element-1 (LINE1) repetitive elements. Samples were from a case-control study derived from a cohort of high-risk breast cancer families (KConFab) and nested case-control studies in two prospective cohorts: Breakthrough Generations Study (BGS) and European Prospective Investigation into Cancer and Nutrition (EPIC). Bisulfite pyrosequencing was used to quantify methylation from 640 incident cases of invasive breast cancer and 741 controls. Quintile analyses for ATMmvp2a showed an increased risk of breast cancer limited to women in the highest quintile [OR, 1.89; 95% confidence interval (CI), 1.36-2.64; P = 1.64 × 10(-4)]. We found no significant differences in estimates across studies or in analyses stratified by family history or menopausal status. However, a more consistent association was observed in younger than in older women and individually significant in KConFab and BGS, but not EPIC. We observed no differences in LINE1 or ATMmvp2b methylation between cases and controls. Together, our findings indicate that WBC DNA methylation levels at ATM could be a marker of breast cancer risk and further support the pursuit of epigenome-wide association studies of peripheral blood DNA methylation.

[1]  James D. Brenton,et al.  Somatically acquired hypomethylation of IGF2 in breast and colorectal cancer , 2008, Human molecular genetics.

[2]  H. Brenner,et al.  Epigenotyping in Peripheral Blood Cell DNA and Breast Cancer Risk: A Proof of Principle Study , 2008, PloS one.

[3]  Antonella Zanobetti,et al.  Rapid DNA methylation changes after exposure to traffic particles. , 2009, American journal of respiratory and critical care medicine.

[4]  W. Chung,et al.  Global DNA methylation levels in girls with and without a family history of breast cancer , 2011, Epigenetics.

[5]  E Riboli,et al.  The EPIC Project: rationale and study design. European Prospective Investigation into Cancer and Nutrition. , 1997, International journal of epidemiology.

[6]  John L Hopper,et al.  Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource , 2006, Breast Cancer Research.

[7]  M. Nesline,et al.  Association between global DNA hypomethylation in leukocytes and risk of breast cancer , 2009, Carcinogenesis.

[8]  A. Feinberg,et al.  Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.

[9]  J. Mill,et al.  Allele-specific methylation in the human genome , 2010, Epigenetics.

[10]  Margaret R Karagas,et al.  DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[11]  N. Dalay,et al.  Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients. , 2010, Anticancer research.

[12]  Bernhard Korn,et al.  Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. , 2011, American journal of human genetics.

[13]  Andrew P Feinberg,et al.  An integrated epigenetic and genetic approach to common human disease. , 2004, Trends in genetics : TIG.

[14]  J. Barrett,et al.  Environmental exposure, DNA methylation, and gene regulation: lessons from diethylstilbesterol-induced cancers. , 2003, Annals of the New York Academy of Sciences.

[15]  Andrew P Feinberg,et al.  The epigenetics of cancer etiology. , 2004, Seminars in cancer biology.

[16]  Xin Liu,et al.  Low-dose radiation-induced responses: Focusing on epigenetic regulation , 2010, International journal of radiation biology.

[17]  Mariza de Andrade,et al.  Leukocyte DNA Methylation Signature Differentiates Pancreatic Cancer Patients from Healthy Controls , 2011, PloS one.

[18]  Paolo Vineis,et al.  DNA methylation changes associated with cancer risk factors and blood levels of vitamin metabolites in a prospective study , 2011, Epigenetics.

[19]  E. Andres Houseman,et al.  Global DNA Methylation Level in Whole Blood as a Biomarker in Head and Neck Squamous Cell Carcinoma , 2007, Cancer Epidemiology Biomarkers & Prevention.

[20]  Owen T McCann,et al.  Human aging-associated DNA hypermethylation occurs preferentially at bivalent chromatin domains. , 2010, Genome research.

[21]  Peter Simpson,et al.  DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status. , 2010, American journal of human genetics.

[22]  A. Teschendorff,et al.  An Epigenetic Signature in Peripheral Blood Predicts Active Ovarian Cancer , 2009, PloS one.

[23]  Rondi A. Butler,et al.  Implications of LINE1 Methylation for Bladder Cancer Risk in Women , 2010, Clinical Cancer Research.

[24]  C. Marsit,et al.  LINE‐1 hypomethylation is associated with bladder cancer risk among nonsmoking Chinese , 2012, International journal of cancer.

[25]  O. Kovalchuk,et al.  Methylation changes in muscle and liver tissues of male and female mice exposed to acute and chronic low-dose X-ray-irradiation. , 2004, Mutation research.

[26]  Huidong Shi,et al.  Obesity related methylation changes in DNA of peripheral blood leukocytes , 2010, BMC medicine.

[27]  B. Christensen,et al.  Breast Cancer DNA Methylation Profiles Are Associated with Tumor Size and Alcohol and Folate Intake , 2010, PLoS genetics.

[28]  Martin J. Aryee,et al.  Personalized Epigenomic Signatures That Are Stable Over Time and Covary with Body Mass Index , 2010, Science Translational Medicine.

[29]  D. Balding,et al.  Epigenome-wide association studies for common human diseases , 2011, Nature Reviews Genetics.

[30]  Peter A. Jones,et al.  The Epigenomics of Cancer , 2007, Cell.

[31]  A. Ashworth,et al.  The Breakthrough Generations Study: design of a long-term UK cohort study to investigate breast cancer aetiology , 2011, British Journal of Cancer.

[32]  E. Huang,et al.  Integrating Factor Analysis and a Transgenic Mouse Model to Reveal a Peripheral Blood Predictor of Breast Tumors , 2011, BMC Medical Genomics.

[33]  Elio Riboli,et al.  The EPIC Project: Rationale and study design , 1997 .

[34]  J. C. Barrett,et al.  Environmental Exposure, DNA Methylation, and Gene Regulation , 2003 .

[35]  R. Jirtle.  IGF2 loss of imprinting: a potential heritable risk factor for colorectal cancer. , 2004, Gastroenterology.

[36]  Maurice B Loughrey,et al.  BRCA1 promoter methylation in peripheral blood DNA of mutation negative familial breast cancer patients with a BRCA1 tumour phenotype , 2008, Breast Cancer Research.

[37]  J. Flanagan,et al.  Intragenic DNA methylation: implications of this epigenetic mechanism for cancer research , 2011, British Journal of Cancer.

[38]  Graham G. Giles,et al.  Constitutional Methylation of the BRCA1 Promoter Is Specifically Associated with BRCA1 Mutation-Associated Pathology in Early-Onset Breast Cancer , 2010, Cancer Prevention Research.

[39]  Wolfgang Viechtbauer,et al.  Conducting Meta-Analyses in R with the metafor Package , 2010 .

[40]  A. Feinberg,et al.  Genome-wide methylation analysis of human colon cancer reveals similar hypo- and hypermethylation at conserved tissue-specific CpG island shores , 2008, Nature Genetics.

[41]  A. Feinberg,et al.  Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. , 2004, Gastroenterology.

[42]  Debra Silverman,et al.  Genomic DNA hypomethylation as a biomarker for bladder cancer susceptibility in the Spanish Bladder Cancer Study: a case-control study. , 2008, The Lancet. Oncology.

[43]  T. Taguchi,et al.  BRCA1 promoter methylation in peripheral blood cells is associated with increased risk of breast cancer with BRCA1 promoter methylation , 2011, Breast Cancer Research and Treatment.

[44]  Wolfgang Wagner,et al.  Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. , 2010, Genome research.

[45]  A. Feinberg,et al.  Loss of imprinting in colorectal cancer linked to hypomethylation of H19 and IGF2. , 2002, Cancer research.

[46]  J. Peto,et al.  Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients , 2009, Human molecular genetics.